logo-loader

Small Cap Wrap

Small Cap Wrap: MTI Wireless Edge; World High Life; Crossword Cybersecurity and mroe...

Small Cap Wrap: Nakama Group; Gfnity; World High Life and more...

 

Set menu

AIM:

 

Total number of AIM Companies (Incl Susp):

880*

Total number of AIM Companies trading:

795*

*as at close of business 16 September 2019

 

Standard List**  of Main Market:

Total number of Standard List Companies

(Incl Susp):

166*

Total number of Standard List Companies trading:

144*

*as at close of business 16 September 2019

 

NEX Growth Market:

 

Total number of NEX Growth Market Companies (Incl Susp):

88*

Total number of NEX Growth Market Companies trading:

86*               

*as at close of business 16 September 2019

*A corporate client of Hybridan LLP

**  Standard Listing as defined by Hybridan LLP to be a business with strictly operational activity

 

 

Dish of the day

No Joiners Today

Off the menu

No Leavers Today

 

 

What’s cooking in the IPO kitchen?

AIM

AMRYT PHARMA PLC (LON:AMYT— a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare or orphan diseases have raised $60m before expenses and will relist on the AIM Market on the 25/09/2019 

Main Market Standard

VAALCO Energy, Inc. (NYSE: EGY), an independent energy company focused on development and production assets in West Africa, today announces its formal intention to seek a Standard Listing on the Main Market of London Stock Exchange ("LSE"), to complement its existing Listing on the New York Stock Exchange. 

Kaspi.kz, the largest Payments, Marketplace and Fintech Ecosystem in Kazakhstan with a leading market share in each of its key products and services, announces today the expected publication of a registration document that has been submitted for approval to the FCA and its potential intention, subject to market conditions, to undertake an initial public offering .

Main Market premium

Registration document approved for Helios Towers. The Group provides essential network services, flexible infrastructure solutions and reliable power supply to mobile network operators  in five African growth economies. Revenue increased 7 per cent. year-on-year to US$191m (H1 2018: US$178m), with Adjusted EBITDA up 15 per cent. year-on-year at US$99m (H1 2018: US$86m) for the six months ended 30 June 2019.

 

Banquet Buffet

Nakama Group (AIM:NAK) 1.10p £1.30m

Last week, Nakama Group, the AIM quoted recruitment consultancy working across the UK and Asia providing recruitment and related services for the web, interactive, digital media, IT and business change sectors, announced its final results for the year ended 31 March 2019.

Highlights

Group revenue decreased by 20.2per cent. to £13.4m (2018: £16.8m)

Net fee income reduced by 22.6 per cent. to £4.1m (2018: £5.3m)

Net fee income percentage decreased to 30.8 per cent. (2018: 31.6 per cent.)

Operating profit increased to £91,000 (2018: loss £1,480,000)

“Trading so far this year has been in line with expectations, however, exceptional costs will be incurred as we continue the restructuring of some local offices. Attracting strong talent and building a higher performance culture takes time and therefore we remain cautious on increasing operating profit margin. Our objective is to continue to focus on financial discipline and improving revenues and profit margins over the year ahead.”

 

 

Gfinity (LON:GFIN) 4p £19.18m

Gfinity, a world-leading esports solutions provider, provides an update on a growing capability and revenue stream.

Gfinity specialises in the design, development and delivery of bespoke esports solutions for publishers, rights holders, brands and media organisations who are looking to connect or deepen relationships with young gamers. One of the solutions is community building and engagement.

Gfinity has built a rapidly growing and unique community of gamers via its online channels, organically connecting with more than 20 million gamers in the past four weeks. Through the provision of regular high-quality news, opinion pieces and creative content via RealSport101, a wholly owned Gfinity company, and Gfinityesports.com and their respective social media channels, Gfinity is featured in the regular media consumption habits of millions of young gamers.

Since April, RealSport101.com has seen a 42% increase in visitors, reaching 150,000 gamers every day with more than 2.5 million people regularly engaging via its Facebook page.  In addition, Gfinityesports.com is continuing to attract a growing number of visitors, attracting 1 million viewers for the first time this month.

 

World High Life (LIFE) 11p £13.2m

World High Life Plc, a CBD and medicinal cannabis investment company, announced that it has agreed indicative terms for the Company's first investment, the acquisition of Love Hemp Ltd . The Directors of World High Life believe that this initial investment will provide LIFE with a platform  from which it can work with Love Hemp to rapidly expand its UK and European business and help LIFE in its ambition to become a leading European medical cannabis and CBD investment company.

Highlights:

World High Life is proposing to acquire Love Hemp for a minimum consideration of £9 million

Love Hemp is a London-based supplier of a range of CBD and Hemp products

Love Hemp already has distribution agreements in place with UK supermarkets and health food stores

The Directors of World High Life believe that this investment and their expertise in the Cannabis sector will enable Love Hemp to accelerate its planned expansion

In the year ended 30 June 2018, Love Hemp made profit before tax of £532,097 on turnover of £2,501,857.

 

Crossword Cybersecurity* (LON:CCS) 456p £23.64m

Crossword Cybersecurity, the cyber security technology commercialisation company, today announced HY Jun 19 results.

Highlights:

Orders received for Rizikon Assurance during the period were more than double those received in the same period last year

The Rizikon Assurance pipeline more than doubled in the first six months of this year and now stands in excess of £3 million over 100 companies in a wide range of sectors

Product and Consulting revenue increased by 21% over the same period in the prior year

Total revenue increased by 5% to £570,757

Total comprehensive loss for the period was £1,077,595, an increase of £246,804 over the same period in the prior year, following investment in product development and sales and marketing

Cash and Cash Equivalents at 30 June 2019 of £1,294,491.

Trading since the period end has continued to be encouraging, and the Directors are confident that full year results will be in line with market expectations.

 

 

PROACTIS Holdings (LON:PHD) 51p £49m

Proactis, the global spend management company, announced that it has signed a long-term contract with DIWIDAG Systems International in Germany.

As announced at the time of the Interim Results during April 2019 the Group took a strategic decision to focus more tightly on a specific market segment with a focussed product portfolio with a view to improving its new business performance in the US, France and Germany.

This contract win represents a strategically important milestone, being the first new customer in Germany to sign up under that new strategy. This demonstrates the capability of its marketing and sales team to align its efforts to the needs of customers within that specific market segment and the suitability of the focussed product portfolio for that market segment.

 

Intelligent Ultrasound (LON:MED) 10.5p £22.55m

Intelligent Ultrasound, the intelligent ultrasound software and simulation company, announces that its database used in the development of its artificial intelligence ("AI") products now exceeds four million ultrasound images.

The continued growth of the Group's image database is an important component of the Company's strategy, as the image library will help it develop additional AI-based software solutions that can automatically recognise and assess ultrasound images to improve the speed and quality of medical ultrasound scanning across a number of clinical applications.

In July 2019, the Group announced that it had signed its first long term licence and co-development agreement for its AI software with one of the world's leading ultrasound equipment manufacturers. The long-term agreement will enable the integration of Intelligent Ultrasound's real-time image analysis software onto a range of specialty specific ultrasound systems within the global healthcare market.

 

Osirium Technologies (LON:OSI) 48p £6.17m

Osirium Technologies, a leading vendor of cloud-based cybersecurity software, announced a significant contract win with a major UK provider of software and IT services to the public sector. The contract represents a substantial expansion by this customer of its investment in Osirium, following an initial order, as announced on 12 February.

Under the terms of the contract, Osirium will deliver its full PxM Platform including the Privileged Access Management, Privileged Task Management and Privileged Session Management modules. The 36 month license is for 2,600 devices, in addition to the 250 devices covered by the initial order. Osirium's software will enable this service provider to deliver managed security services to its customers, principally central government organisations and local authoriities in the public sector, delivering rigorous control of access to privileged accounts.

 

4D PHARMA (LON:DDDD) 82p £53.54m

4D pharma, a pharmaceutical company leading the development of Live Biotherapeutics, announced the publication of a paper outlining the ability of MRx0005 and MRx0029 to modulate neuroinflammatory and neurodegenerative processes in vitro.

The paper 'In vitro characterisation of gut microbiota-derived bacterial strains with neuroprotective properties' is published in the journal Frontiers in Cellular Neuroscience.

Through screening a panel of gut bacterial strains using the Company's MicroRx® platform, 4D researchers have identified two single-strain Live Biotherapeutic candidates, MRx0005 and MRx0029 with potent effects on neuroinflammation and intrinsic antioxidant capacity. MRx0029 also displayed neuroprotective properties and induced a mature phenotype in undifferentiated neuronal cells. The team were able to associate many of the observed effects with specific short-chain fatty acids produced by the bacteria

 

MTI Wireless Edge (LON:MWE) 31p £26.23m

MTI Wireless Edge Ltd, the technology group, focused on comprehensive communication and radio frequency solutions across multiple sectors, announced that its antenna division has received an order valued at approximately US$1 million, for the supply of military antennas to a European customer over the next 15 months.

 

Thruvision Group (LON:THRU) 27.60p £39.13m

Thruvision the specialist provider of people-screening technology to the international security market, announced a strategically important contract award by the US Government's Customs and Border Protection (CBP) totalling $3.0 million, of which $2.9 million will be delivered in FY20.

 

 

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: PharmaCielo looking to 2020 as a transformative year for the...

PharmaCielo (CVE: PCLO) Chief Corporate Officer David Gordon joined Steve Darling from Proactive in Toronto to talk about the cannabis company whose operations are in Colombia. Gordon talked about the facilities they have and the advantages the climate in Colombia has for...

13 hours, 59 minutes ago

8 min read